Food & Health
Law & Insurance
Nano & Biomaterials
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
GeneReach- from samples to results, your one-stop solution for mulecular diagnostics is looking for distributors
GeneReach Biotechnology Corporation (GeneReach), founded in 1993, is a supplier of viral and genetic diagnosis products. Since 1995, we have focused our R&D on viral diagnosis associated with aquaculture species, especially penaeid shrimps and salt water fishes. At GeneReach, we provide not only the reagents for diagnosis but also full technical support programs for our products. After suc...
No relief for alcoholics yet after Lundbeck Phase III results
Danish pharmaceutical company H. Lundbeck A/S yesterday unveiled clinical data on its potential blockbuster drug nalmefene at the 2012 European Congress of Psychiatry clinical in Prague. Whil...
China placing priority on biotechnology
China will spend 2 trillion yuan ($308.5 billion) on science and technology, making biotechnology a major priority, in the next five years, Chinese State Councilor Liu Yandong said at the ong...
Monitoring Critical Conditions for Quality and Compliance
How do life science companies ensure fail-safe monitoring of their controlled environments to maintain uncompromised product quality? They rely on a Vaisala Veriteq Continuous Monitoring Syst...
Stanford researchers separate tumor-causing stem cells from therapeutic one
A major obstacle to widespread therapeutic use of human embryonic stem cells in therapy is this nasty tendency for a few of them to turn "Frankenstein" on us. Out of the tens of millions of p...
iNovacia Further Develops its Compound Collection
iNovacia, the drug discovery service provider and subsidiary of Kancera AB (Nasdaq OMX Stockholm First North, KAN), today announced the addition of over 20,000 novel compounds to its small-mo...
Protein in spinal fluid appears to predict Alzheimers
In the absence of a cure for Alzheimers disease, scientists are focusing a great deal of effort on early detection and diagnosis, so perhaps symptoms can be postponed. German researchers beli...
Several methods for early diagnosis of Alzheimers disease developed by European scientists
Several methods for early diagnosis of Alzheimers disease developed by European scientistsPredictAD is an EU-funded research project that develops objective and efficient methods for enabling...
All eyes on pSivida for back-of-the-eye drug delivery
pSivida is getting more and more attention these days as a drug-delivery company to watch, especially as it develops products for a potentially huge market--easy delivery of medicine for glau...
UK Biotech Company Leading Fight to Cure E. coli
A Cambridge-based biotech company is leading the fight againstpotentially fatal bacteria such as MRSA and E. coli, attracting new fundingto develop its pioneering treatment which could play a...
The "tau" of Alzheimer´s, or how a protein causes the death of neurons
There is a general consensus that extracellular amyloid-beta (Aß) plaques are the villains that cause Alzheimers disease and the death of neurons. But, other than identifying amyloid-beta in ...
Thermo Fisher Scientific Launches New GC-MS/MS Instrument for Superior Selectivity and Sensitivity at ASMS 2011
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to ...
Stem cell technology used in unique surgery in Gothenburg
Prof. Michael Olausson, responsible for the unique surgery at Sahlgrenska University Hospital.Photo: Björn Larsson RosvallFor the first time ever in the world, researchers at the Sahlgrenska ...
Intelligent throughput service
From target identification to pre-clinical testing and clinical data management and biostatistics, SBW help their clients reach their research goals by thoroughly explaining what the findings...
Clustering for success
Clustering is very popular these days and a cluster that has been successful in recent years is the Oslo Cancer Cluster (OCC). One of its members is Semcon.Anna Thorssell Bertland, Business Develop...
Nordiag and Molzym enter into first sepsis agreement
Sepsis is one of the leading cause of death in hospitals world-wide. On March 17, it was announced that Molzym has entered into an agreement with Seegene for delivery of reagents based on their mol...
New Osteoporosis Assay From Astra Biotech Gmbh
Osteoporosis affects over 75 million people worldwide and in a single year there are more than 9 million instances of osteoporotic fractures making it the fourth most significant non-infectio...
Stem cells in therapy – Advantage Gothenburg
One-third of the world’s stem cell research programmes are to be found in Sweden and more than half of these are in Gothenburg.CLUSTER: With the potential to transform disease treatment, redu...
Vironova leads Flucure project
TEM image of influenza virus The Swedish biotech company developing novel antiviral therapeutics and virus diagnostics, Vironova, leads a new influenza drug development programme with EU fundi...
Competing with competence and commitment
Celebrating its fifth anniversary, independent CRO Commitum is expanding its range of services and number of employees.CONTRACT RESEARCH: Though several clinical units have closed as a result...
Your partner in North America
With their wide expertise, low overhead costs, good relations with both Health Canada and the FDA and a vast array of partners, SPharm, has turned out to be a competitive choice when searchin...
Supply chain compliance in global clinical research
A recent study conducted by UK-based Medicines and Healthcare Products Regulatory Agency (MHRA) found that a stunning 43% of critical and major product deficiencies are related to ineffective tempe...
EMEA and FDA recommend data monitoring committees
Both the FDA and EMEA strongly recommend that a Data Monitoring Committee (DMC) is set up when conducting a clinical trial, especially if the trial is conducted on a vulnerable population or ...
Is a preferred partner agreement always preferable?
Local CROs may offer greater flexibility and more accurate services than a CRO headquartered in another continent. Yet, they are sifted out by PPAs for not being global. CONTRACT RESEARCH Conducti...
Global in mind – local at heart
Starting his own CRO at the age of 25, Daniel Spasic was recently recognised as a good role model for future entrepreneurs. SCANDINAVIAN ENTREPRENEUR On February 4th, Daniel Spasic, TFS’ Chief Exe...
Consolidated CRO connects east and west
SBW Ltd is well-positioned to handle the restructuring of the pharma industry, where both India and China are becoming all the more important destinations for pharma research and development....
Preclinical CROs create value in drug development process
Using a CRO, a big pharma company can save weeks in the drug development process, while an SME may save even months of research time.CONTRACT RESEARCH Using a CRO to add value in early drug d...
Stem Cells in Breastmilk
The theory developed in 2007 by scientists at the University of Western Australia (UWA) that breastmilk contains stem cells has been taken to a higher level with the latest discovery by one of the ...